Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dany Anglicheau

Showing results (21-30 of 271) with videos related to

Pageof 28
Sort By:
Nephrologie & Therapeutique|September 13, 2006
[Nephrotoxicity of sirolimus: experimental and clinical data]Nicolas Pallet, Eric Thervet, Christophe Legendre, et al.
Pharmacogenomics|February 23, 2005
Cytochrome P450 3A polymorphisms and immunosuppressive drugsEric Thervet, Christopher Legendre, Philippe Beaune, et al.
Therapeutic Drug Monitoring|March 28, 2008
Role of pharmacogenetics of immunosuppressive drugs in organ transplantationEric Thervet, Dany Anglicheau, Christophe Legendre, et al.
Human Immunology|May 6, 2019
Sensitization to endothelial cell antigens: Unraveling the cause or effect paradoxAnnette M Jackson, Marianne Delville, Baptiste Lamarthée, et al.
Human Immunology|May 31, 2016
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?Marianne Delville, Béatrice Charreau, Marion Rabant, et al.
Transplantation|August 2, 2016
Establishing Biomarkers in Transplant Medicine: A Critical Review of Current ApproachesDany Anglicheau, Maarten Naesens, Marie Essig, et al.
Nephrologie & Therapeutique|March 16, 2016
[Renal elastography]Jean-Michel Correas, Dany Anglicheau, Jean-Luc Gennisson, et al.
Medecine Sciences : M/S|November 15, 2006
[mTOR inhibitors: pleiotropic antiproliferative drugs]Nicolas Pallet, Philippe Beaune, Eric Thervet, et al.
Frontiers in Immunology|April 8, 2022
Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying MechanismsEmilie Lebraud, Maëva Eloudzeri, Marion Rabant, et al.
Pharmacogenomics|December 16, 2016
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomesAdrien Flahault, Dany Anglicheau, Marie-Anne Loriot, et al.
Pageof 28

Showing results (21-30 of 271) with videos related to

Sort By:
Pageof 28
Nephrologie & Therapeutique|September 13, 2006
[Nephrotoxicity of sirolimus: experimental and clinical data]Nicolas Pallet, Eric Thervet, Christophe Legendre, et al.
Pharmacogenomics|February 23, 2005
Cytochrome P450 3A polymorphisms and immunosuppressive drugsEric Thervet, Christopher Legendre, Philippe Beaune, et al.
Therapeutic Drug Monitoring|March 28, 2008
Role of pharmacogenetics of immunosuppressive drugs in organ transplantationEric Thervet, Dany Anglicheau, Christophe Legendre, et al.
Human Immunology|May 6, 2019
Sensitization to endothelial cell antigens: Unraveling the cause or effect paradoxAnnette M Jackson, Marianne Delville, Baptiste Lamarthée, et al.
Human Immunology|May 31, 2016
Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?Marianne Delville, Béatrice Charreau, Marion Rabant, et al.
Transplantation|August 2, 2016
Establishing Biomarkers in Transplant Medicine: A Critical Review of Current ApproachesDany Anglicheau, Maarten Naesens, Marie Essig, et al.
Nephrologie & Therapeutique|March 16, 2016
[Renal elastography]Jean-Michel Correas, Dany Anglicheau, Jean-Luc Gennisson, et al.
Medecine Sciences : M/S|November 15, 2006
[mTOR inhibitors: pleiotropic antiproliferative drugs]Nicolas Pallet, Philippe Beaune, Eric Thervet, et al.
Frontiers in Immunology|April 8, 2022
Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying MechanismsEmilie Lebraud, Maëva Eloudzeri, Marion Rabant, et al.
Pharmacogenomics|December 16, 2016
Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomesAdrien Flahault, Dany Anglicheau, Marie-Anne Loriot, et al.
Pageof 28